IAP CMS Commentary

As the need for developing robust approaches for addressing substance use disorders becomes increasingly clear, CMS has been working directly with a set of leader states through our Medicaid Innovation Accelerator Program (IAP). Seven states participate in an intensive learning collaborative and 48...

What a year of growth that 2015 has been for IAP! In last year’s December commentary I announced the program priority areas that we had selected for IAP. It was a long selection process that included many internal and external discussions. In thinking back to this time last year, two things...

Thank you to everyone who participated in the IAP Substance Use Disorder (SUD) webinar on November 7th. The goal of the webinar was to provide states with details on the upcoming High-Intensity Learning Collaborative as well as additional opportunities to participate in the SUD initiative. The...

We are excited to confirm that the first IAP focus area will address strategies to improve states substance use disorder (SUD) treatment systems. SUD is a serious and growing problem in the U.S., but evidence is also strong for the efficacy and cost-effectiveness of treatment. Based on...

We had a great in-person meeting on Monday in Baltimore with over 25 representatives from states joining us in the morning and an equal number of consumer advocates and providers for the afternoon session. We were thrilled with the thoughtful discussion and helpful feedback. As we hoped, these...

This week, we are hosting the first in a series of in-person meetings across the country to begin the conversation about our Medicaid Innovation Accelerator Program (IAP), a new initiative that we are launching in partnership with the Center for Medicare and Medicaid Innovation. We launched...